Page 1 od 306 rezultati
CROSS REFERENCES TO RELATED APPLICATIONS
Not Applicable
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH
Not Applicable
REFERENCE TO APPENDIX
Not Applicable
BACKGROUND OF THE INVENTION
A. Field of the Invention
The present invention relates to the field of nausea relieving formulas, more
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to non-chemical means for reducing and alleviating nausea. The invention utilizes electrical current passed through an acupuncture site on the human body for the control of nausea.
2. Description of the Prior Art
Although
BACKGROUND
Migraine is a condition that affects approximately 28 million people in the United States, with females more frequently affected than males (Silberstein, Neurology, 2000 55:754-63). Migraine headache is associated with a painful vasodilation of cranial vessels that typically manifests in
BACKGROUND
Migraine is a condition that affects approximately 28 million people in the United States, with females more frequently affected than males (Silberstein, Neurology, 2000 55:754-63). Migraine headache is associated with a painful vasodilation of cranial vessels that typically manifests in
The present invention relates to the use of substituted 2-thio-3,5-dicyano4-phenyl-6-amino-pyridines of the formula (I) for production of a medicament for the treatment of nausea and vomiting.
It is known that both adenosine phosphates and adenosine itself in general lead to a more rapid recovery of
TECHNICAL FIELD
The present invention generally relates to pharmaceutical compositions and dosage systems, such as pharmaceutical compositions and dosage systems useful for the management of nausea and vomiting, such as for the prevention and/or treatment of nausea and vomiting of pregnancy
FIELD OF THE INVENTION
The present invention generally relates to pharmaceutical compositions and dosage systems, such as pharmaceutical compositions and dosage systems useful for the management of nausea and vomiting, such as for the prevention and/or treatment of nausea and vomiting of pregnancy
FIELD OF THE INVENTION
The present invention generally relates to pharmaceutical compositions and dosage systems, such as pharmaceutical compositions and dosage systems useful for the management of nausea and vomiting, such as for the prevention and/or treatment of nausea and vomiting of pregnancy
1. FIELD OF THE INVENTION
The present invention provides methods of administering an insulinotropic peptide in an amount effective to treat a disorder or condition while reducing nausea. Exemplary disorders or conditions treatable with an insulinotropic peptide include obesity and type II
FIELD OF THE INVENTION
The present invention relates to an analgesic formulation for pain control not limited to postoperative pain control.
BACKGROUND OF THE INVENTION
The treatment and relief of pain is one of the most common reasons patients seek medical evaluation. Pain has been defined by the
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NK.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NK.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NK.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NI.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NK.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The